跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clindalon - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Clindalon
Approved
STANDARD
Clindalon
Alvita Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e1f66ae466b5cca4
Company
Alvita Pharma Private Limited
Type
Standard
Approval Details
Approval Id
e1f66ae466b5cca4
Drug Approval Philippines Name
Clindalon
Product Name
Clindalon
Registration Number
DRP-5676-03
Brand Name
Clindalon
Generic Name
Clindamycin (as phosphate)
Dosage Form
Solution For Injection (IM/IV)
Dosage Strength
150 mg/mL
Manufacturer
Alvita Pharma Private Limited
Importer
MedEthix, Inc.
Distributor
Vivilon Pharmaceuticals Inc
Issuance Date
29 June 2024
Expiry Date
29 October 2029
Pharmacologic Category
Antibacterial
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e1f66ae466b5cca4
Type
Standard
Back to Philippines FDA Approvals